{
  "id": 594,
  "text": "</td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negati\n\n<question>: ",
  "ChatGPT_response_0": "根據世界衛生組織的建議，對於一般人群中已經接受治療的女性進行HPV DNA檢測是合理的。這項建議是基於對嚴重宮頸上皮變性（CIN）2/3或腺癌原位癌（AIS）等病變的治療後追蹤的需要，有助於確保治療效果和預防復發。HPV DNA檢測具有更高的敏感性和特異性，可以提供更可靠的結果，有助於做出更準確的評估和後續處理決策。因此，在這樣的案例中，選擇使用HPV DNA檢測是符合標準的做法。",
  "query": "在這種情況下，WHO建議對於一般人群中已經接受治療的女性進行HPV DNA檢測，而不是細胞學檢測或聯合測試。這樣的建議是否合理？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在這種情況下，WHO建議對於一般人群中已經接受治療的女性進行HPV DNA檢測，而不是細胞學檢測或聯合測試。這樣的建議是否合理？\n\n<reference text>: </td><td>Conditional recommendation low-certainty evidence </td></tr><tr><td>13.WHO suggests that women from the general population who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VlA or co-testing, and, if negative, move to the recommended regular screening interval.\n\n<reply>: ",
  "response": "根據世界衛生組織的建議，對於一般人群中已經接受治療的女性進行HPV DNA檢測是合理的。這項建議是基於對嚴重宮頸上皮變性（CIN）2/3或腺癌原位癌（AIS）等病變的治療後追蹤的需要，有助於確保治療效果和預防復發。HPV DNA檢測具有更高的敏感性和特異性，可以提供更可靠的結果，有助於做出更準確的評估和後續處理決策。因此，在這樣的案例中，選擇使用HPV DNA檢測是符合標準的做法。"
}